Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 10, 2024

Neoadjuvant Chemotherapy for High-Grade Myxoid Liposarcoma

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
J. Clin. Oncol 2024 Jan 17;[EPub Ahead of Print], A Gronchi, E Palmerini, V Quagliuolo, J Martin Broto, A Lopez Pousa, G Grignani, A Brunello, JY Blay, O Tendero, R Diaz Beveridge, V Ferraresi, I Lugowska, S Pizzamiglio, P Verderio, V Fontana, DM Donati, E Palassini, R Sanfilippo, G Bianchi, A Bertuzzi, C Morosi, S Pasquali, S Stacchiotti, S Bagué, JM Coindre, R Miceli, AP Dei Tos, PG Casali

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading